Amedeo Smart

Free Medical Literature Service

 

Amedeo

Anemia
  Free Subscription

Articles published in
Br J Haematol
    April 2024
  1. ARCANJO GS, Souza MB, Domingos IF, Pereira-Martins DA, et al
    BMP6 and VDR gene polymorphisms are associated with osteonecrosis in a sickle cell anaemia cohort.
    Br J Haematol. 2024;204:1507-1514.
    >> Share

  2. CHANG A, Wilson SR, Morris S, Wichlan D, et al
    Nocturnal hypoxaemia is common in adults with sickle cell anaemia.
    Br J Haematol. 2024;204:1495-1499.
    >> Share

  3. JACOBS JW, Sharma D, Stephens LD, Figueroa Villalba CA, et al
    Thrombosis risk with haemoglobin C trait and haemoglobin C disease: A systematic review.
    Br J Haematol. 2024;204:1500-1506.
    >> Share

  4. KUNVARJEE B, Contreras Yametti GP, Blouin AG, Linder GE, et al
    Donor-specific antibody desensitization with daratumumab prior to haematopoietic cell transplant for sickle cell disease: A case report.
    Br J Haematol. 2024;204:1540-1544.
    >> Share

    March 2024
  5. EBEA-UGWUANYI PO, Vidyasagar S, Connor JR, Frazer DM, et al
    Oral iron therapy: Current concepts and future prospects for improving efficacy and outcomes.
    Br J Haematol. 2024;204:759-773.
    >> Share

  6. KULASEKARARAJ A, Cavenagh J, Dokal I, Foukaneli T, et al
    Guidelines for the diagnosis and management of adult aplastic anaemia: A British Society for Haematology Guideline.
    Br J Haematol. 2024;204:784-804.
    >> Share

  7. LEE GM, Batchvarova M, Delahunty M, Boateng L, et al
    Sickle red blood cells directly activate neutrophils.
    Br J Haematol. 2024;204:e28-e30.
    >> Share

  8. JONASSAINT CR, Parchuri E, O'Brien JA, Lalama CM, et al
    Mental health, pain and likelihood of opioid misuse among adults with sickle cell disease.
    Br J Haematol. 2024;204:1029-1038.
    >> Share

  9. HANSEN DL, Maquet J, Lafaurie M, Moller S, et al
    Primary autoimmune haemolytic anaemia is associated with increased risk of ischaemic stroke: A binational cohort study from Denmark and France.
    Br J Haematol. 2024;204:1072-1081.
    >> Share

  10. EARLY ML, Raja M, Luo A, Solow M, et al
    Blood pressure thresholds for the diagnosis of hypertensive disorders of pregnancy in sickle cell disease.
    Br J Haematol. 2024;204:1039-1046.
    >> Share

  11. KISALI EP, Iversen PO, Makani J
    Low vitamin B(12) blood levels in sickle cell disease: Data from a large cohort study in Tanzania.
    Br J Haematol. 2024;204:1047-1053.
    >> Share

  12. STEINBERG-SHEMER O, Yacobovich J, Noy-Lotan S, Dgany O, et al
    Biallelic hypomorphic variants in CAD cause uridine-responsive macrocytic anaemia with elevated haemoglobin-A2.
    Br J Haematol. 2024;204:1067-1071.
    >> Share

  13. LIU H, Ding K, Zhang W, Xing L, et al
    A pilot study of orelabrutinib treatment in three cases of refractory/relapsed autoimmune haemolytic anaemia/Evans syndrome.
    Br J Haematol. 2024;204:1082-1085.
    >> Share

  14. MUNARETTO V, Corti P, Bertoni E, Tripodi SI, et al
    Acute chest syndrome in children with sickle cell disease: Data from a national AIEOP cohort identify priority areas of intervention in a hub-and-spoke system.
    Br J Haematol. 2024;204:1061-1066.
    >> Share

    February 2024
  15. WARE RE, Quinn CT
    The bold promise of gene therapy for sickle cell disease.
    Br J Haematol. 2024;204:381-382.
    >> Share

  16. STEENSMA DP
    Revisiting the first reported case of aplastic anaemia.
    Br J Haematol. 2024;204:455-458.
    >> Share

  17. KATAGIRI T, Iwasaki H, Fujieda A, Kasashima S, et al
    A case of hepatitis-associated aplastic anaemia following living-donor liver transplantation for fulminant hepatitis showing loss of heterozygosity in the 6p chromosome in the affected liver.
    Br J Haematol. 2024;204:623-627.
    >> Share

  18. HUNT RC, Kimchi-Sarfaty C
    A synonymous variant is unmasked in thalassaemia.
    Br J Haematol. 2024;204:399-401.
    >> Share

  19. KHWAJA J, Japzon N, Gabriel M, Raju K, et al
    Cold agglutinin disease and cryoglobulinaemia: A frequent coexistence with clinical impact.
    Br J Haematol. 2024;204:e21-e24.
    >> Share

  20. EARLY ML, Luo A, Solow M, Matusiak K, et al
    Natural history of blood pressure in sickle cell disease pregnancy.
    Br J Haematol. 2024;204:658-667.
    >> Share

  21. CHAKRAVORTY S, Drasar E, Kaya B, Kesse-Adu R, et al
    UK Haemoglobin Disorders Peer Review: A Quality Standards-based review programme for sickle cell disease and thalassaemia.
    Br J Haematol. 2024;204:668-676.
    >> Share

  22. SISLER I, McClish DK, Villella A, Valrie C, et al
    Impact of community health workers on quality of life in adolescents and young adults with sickle cell disease: The SHIP-HU study.
    Br J Haematol. 2024;204:649-657.
    >> Share

  23. GORIVALE M, Sawant P, Kargutkar N, Hariharan P, et al
    When a synonymous mutation breaks the silence in a thalassaemia patient.
    Br J Haematol. 2024;204:677-682.
    >> Share

    January 2024
  24. OYARBIDE U, Crane GM, Corey SJ
    The metabolic basis of inherited neutropenias.
    Br J Haematol. 2024;204:45-55.
    >> Share

  25. PETERS C
    Haematopoietic stem cell transplantation in children with sickle cell disease: Still to do?
    Br J Haematol. 2024;204:22-23.
    >> Share

  26. DANIEL Y, Henthorn J
    Lessons learnt in the screening and diagnosis of haemoglobinopathies.
    Br J Haematol. 2024;204:68-73.
    >> Share

  27. SHOOK LM, Ware RE
    Screening for haemoglobin disorders: One size may not fit all.
    Br J Haematol. 2024;204:26-28.
    >> Share

  28. CSEH A, Galimard JE, de la Fuente J, Isgro A, et al
    Busulfan-fludarabine- or treosulfan-fludarabine-based conditioning before allogeneic HSCT from matched sibling donors in paediatric patients with sickle cell disease: A study on behalf of the EBMT Paediatric Diseases and Inborn Errors Working Parties.
    Br J Haematol. 2024;204:e1-e5.
    >> Share

  29. GUINDO A, Cisse Z, Keita I, Desmonde S, et al
    Potential for a large-scale newborn screening strategy for sickle cell disease in Mali: A comparative diagnostic performance study of two rapid diagnostic tests (SickleScan(R) and HemotypeSC(R)) on cord blood.
    Br J Haematol. 2024;204:337-345.
    >> Share

  30. ALLALI S, Marquant F, Rignault-Bricard R, Taylor M, et al
    Oral famotidine reduces the plasma level of soluble P-selectin in children with sickle cell disease.
    Br J Haematol. 2024;204:346-351.
    >> Share

    December 2023
  31. PIZZO A, Porter JS, Carroll Y, Burcheri A, et al
    Provider prescription of hydroxyurea in youth and adults with sickle cell disease: A review of prescription barriers and facilitators.
    Br J Haematol. 2023;203:712-721.
    >> Share

  32. MISHKIN AD, Prince EJ, Leimbach EJ, Mapara MY, et al
    Psychiatric comorbidities in adults with sickle cell disease: A narrative review.
    Br J Haematol. 2023;203:747-759.
    >> Share

    November 2023
  33. GREEN NS, Rosano C, Bangirana P, Opoka R, et al
    Neurofilament light chain: A potential biomarker for cerebrovascular disease in children with sickle cell anaemia.
    Br J Haematol. 2023;203:460-467.
    >> Share

  34. BANDINI P, Borras N, Fernandez Mellid E, Martin-Fernandez L, et al
    First description of bone marrow failure syndrome in Spain caused by mutations in the ERCC6L2 gene.
    Br J Haematol. 2023;203:e102-e107.
    >> Share

  35. STEWART GW, Gibson JS, Rees DC
    The cation-leaky hereditary stomatocytosis syndromes: A tale of six proteins.
    Br J Haematol. 2023;203:509-522.
    >> Share

  36. NOVAK W, Berner J, Svaton M, Jimenez-Heredia R, et al
    Evans syndrome caused by a deleterious mutation affecting the adaptor protein SASH3.
    Br J Haematol. 2023;203:678-683.
    >> Share

  37. SCULLY M, Rayment R, Clark A, Westwood JP, et al
    A British Society for Haematology Guideline: Diagnosis and management of thrombotic thrombocytopenic purpura and thrombotic microangiopathies.
    Br J Haematol. 2023;203:546-563.
    >> Share

  38. FERMO E, Zaninoni A, Vercellati C, Marcello AP, et al
    When alpha spectrin null alleles meet low expression alpha spectrin polymorphisms.
    Br J Haematol. 2023;203:684-687.
    >> Share

    October 2023
  39. ALADJIDI N, Pincez T, Rieux-Laucat F, Nugent D, et al
    Paediatric-onset Evans syndrome: Breaking away from refractory immune thrombocytopenia.
    Br J Haematol. 2023;203:28-35.
    >> Share

  40. RANQUE B, Diaw M, Dembele AK, Lapoumeroulie C, et al
    Association of haemolysis markers, blood viscosity and microcirculation function with organ damage in sickle cell disease in sub-Saharan Africa (the BIOCADRE study).
    Br J Haematol. 2023;203:319-326.
    >> Share

  41. ALSULTAN A, Abujoub R, Alsudairy R, Memon S, et al
    Human leucocyte antigen-matched related haematopoietic stem cell transplantation using low-dose cyclophosphamide, fludarabine and thymoglobulin in children with severe aplastic anaemia.
    Br J Haematol. 2023;203:255-263.
    >> Share

  42. HEBBEL RP, Milbauer L, Wei P
    A novel promoter of endothelial dysfunction in African Americans: Relevance to sickle cell anaemia.
    Br J Haematol. 2023;203:e71-e73.
    >> Share

    September 2023
  43. ZHANG Y, Xie H, Liang G, Qin Y, et al
    A novel gain-of-function PIP4K2A mutation elevates the expression of beta-globin and aggravates the severity of alpha-thalassemia.
    Br J Haematol. 2023;202:1018-1023.
    >> Share

  44. NANNELLI C, Bosman A, Cunningham J, Dugue PA, et al
    Genetic variants causing G6PD deficiency: Clinical and biochemical data support new WHO classification.
    Br J Haematol. 2023;202:1024-1032.
    >> Share

  45. DE ALCANTARA PEDRO PP, Castro CHM, Pinheiro MM, Goncalves LM, et al
    Vertebral fractures and low lean mass in young men with sickle cell disease: Lack of association with bone mineral density and clinical characteristics.
    Br J Haematol. 2023;202:e46-e49.
    >> Share

  46. HAN J, Saraf SL, Gordeuk VR
    Vaccination in sickle cell disease: Immunocompromised or immunocompetent?
    Br J Haematol. 2023;202:916-918.
    >> Share

  47. ESPERTI S, Nader E, Boisson C, Carin R, et al
    Mitochondria retention in mature RBCs from haemoglobin SC patients.
    Br J Haematol. 2023;202:e36-e38.
    >> Share

  48. KNIGHT-MADDEN J, King L, Asnani M, Skyers N, et al
    Needs assessment in adults and parents of children living with sickle cell disease in Jamaica.
    Br J Haematol. 2023;202:e31-e35.
    >> Share

  49. NAKAHARA H, Cheedarla N, Verkerke HP, Cheedarla S, et al
    Enhanced IgG immune response to COVID-19 vaccination in patients with sickle cell disease.
    Br J Haematol. 2023;202:937-941.
    >> Share

  50. GUPTA A, Gooda R, Marouf R
    Pseudo-Gaucher cells in a splenectomised Beta-Thalassemia patient.
    Br J Haematol. 2023;202:911.
    >> Share

  51. ZOLLER H, Wagner S, Schaefer B
    What is wrong in doing good?
    Br J Haematol. 2023;202:1089-1090.
    >> Share

  52. ASHER S, Shah R, Ings S, Horder J, et al
    Haematopoietic stem cell mobilisation followed by high-dose chemotherapy and autologous stem cell transplantation for patients with sickle cell disease and myeloma.
    Br J Haematol. 2023;202:1224-1227.
    >> Share

  53. DASARI S, Tse W, Wang J
    Real-world evidence of incidence and outcomes of aplastic anaemia following administration of immune checkpoint inhibitors.
    Br J Haematol. 2023;202:1205-1208.
    >> Share

  54. CHU Z, Cushway T, Wong M, Lim KX, et al
    Incidence and predictors of hypophosphataemia after ferric carboxymaltose use-A 3-year experience from a single institution in Singapore.
    Br J Haematol. 2023;202:1199-1204.
    >> Share

  55. MANGANAS K, Delicou S, Xydaki A, Kourakli A, et al
    Predisposing factors for advanced liver fibrosis in patients with sickle cell disease.
    Br J Haematol. 2023;202:1192-1198.
    >> Share

  56. JACOBS JW, Ding JJ, Tormey CA, Abels EA, et al
    Where do they go? The clinical conundrum of warm autoantibodies and their inability to cause haemolytic disease of the foetus and newborn.
    Br J Haematol. 2023;202:1213-1215.
    >> Share

    August 2023
  57. ELSHERIF L, Kanthakumar P, Afolabi J, Stratton AF, et al
    Urinary angiotensinogen is associated with albuminuria in adults with sickle cell anaemia.
    Br J Haematol. 2023;202:669-673.
    >> Share

  58. GIBSON JS, Stewart GW
    A critical role for altered red cell cation permeability in pathogenesis of sickle cell disease and other haemolytic anaemias.
    Br J Haematol. 2023;202:462-464.
    >> Share

  59. NADER E, Conran N, Leonardo FC, Hatem A, et al
    Piezo1 activation augments sickling propensity and the adhesive properties of sickle red blood cells in a calcium-dependent manner.
    Br J Haematol. 2023;202:657-668.
    >> Share

  60. HAMANI S, Lioure B, Nicolae A, Lipsker D, et al
    A Rare Cause of Refractory Anaemia hidden between Folds.
    Br J Haematol. 2023;202:712.
    >> Share

  61. JOLY P, Nader E, Ketels F, Boisson C, et al
    Effects of pyruvate kinase activators on red blood cell properties in sickle cell disease.
    Br J Haematol. 2023;202:e27-e30.
    >> Share

  62. ZHANG X, Han J, Shah BN, Saraf SL, et al
    Platelet count decline and high neutrophil count within the first day of admission for painful sickle cell vaso-occlusive episodes predict severe complications.
    Br J Haematol. 2023;202:e20-e23.
    >> Share

  63. MARTIN OY, Margulies S, Speller-Brown B, Majumdar S, et al
    The evolution of the COVID-19 pandemic in paediatric patients with sickle cell disease: From Alpha to Omicron.
    Br J Haematol. 2023;202:479-484.
    >> Share

    July 2023
  64. RAI MP, Lee EJ, Bussel JB
    Maintenence rituximab following induction in autoimmune cytopenias.
    Br J Haematol. 2023;202:153-158.
    >> Share

  65. HAROUN E, Dutta D, Lim SH
    Effects of GBT1118, a voxelotor analog, on intestinal pathophysiology in sickle cell disease.
    Br J Haematol. 2023;202:184-194.
    >> Share

  66. FERRONE FA
    More of the same? Voxelotor spawns a successor, but on what success does it build?
    Br J Haematol. 2023;202:13-15.
    >> Share

  67. DUFU K, Alt C, Strutt S, Partridge J, et al
    GBT021601 improves red blood cell health and the pathophysiology of sickle cell disease in a murine model.
    Br J Haematol. 2023;202:173-183.
    >> Share

    June 2023
  68. SHETH S, Taher AT, Coates TD, Kattamis A, et al
    Management of luspatercept therapy in patients with transfusion-dependent beta-thalassaemia.
    Br J Haematol. 2023;201:824-831.
    >> Share

  69. WU J, Wang J, Tang N, Wang X, et al
    An atypical patient with bone marrow failure syndrome-2 without microcephaly and learning disability in a Chinese family.
    Br J Haematol. 2023;201:e50-e53.
    >> Share

  70. LIN Y, Del Giudice ME, Kron A, Meirovich H, et al
    A pilot feasibility trial of daily versus every other day oral iron supplementation in patients with iron deficiency anaemia.
    Br J Haematol. 2023;201:1000-1004.
    >> Share

  71. PENG Y, Liang L, Zhang H, Liu H, et al
    Single-cell profiling of ineffective erythropoiesis in a mouse model of beta-thalassaemia intermedia.
    Br J Haematol. 2023;201:982-994.
    >> Share

  72. BAIN BJ, Daniel Y, Henthorn J, de la Salle B, et al
    Significant haemoglobinopathies: A guideline for screening and diagnosis: A British Society for Haematology Guideline: A British Society for Haematology Guideline.
    Br J Haematol. 2023;201:1047-1065.
    >> Share

  73. JACOBS JW, Stephens LD, Allen ES, Binns TC, et al
    Epidemiological and clinical features, therapeutic strategies and outcomes in patients with hyperhaemolysis: A systematic review.
    Br J Haematol. 2023;201:1025-1032.
    >> Share

  74. GENDREAU S, Cecchini J, Perier F, Razazi K, et al
    Effect of high-flow oxygen therapy on regional oxygen saturation during vaso-occlusive pain crisis: An observational study.
    Br J Haematol. 2023;201:e58-e61.
    >> Share

  75. TAKASAKI K, Friedman DF, Uter S, Vege S, et al
    Variant RHD alleles and Rh immunization in patients with sickle cell disease.
    Br J Haematol. 2023;201:1220-1228.
    >> Share

  76. LI J, Wang Y, Zhang Y, Zhang X, et al
    Haematopoietic stem cell transplantation for hepatitis-associated aplastic anaemia and non-hepatitis-associated aplastic anaemia: A propensity score-matched analysis.
    Br J Haematol. 2023;201:1179-1191.
    >> Share

  77. CHEMINET G, Brunetti A, Khimoud D, Ranque B, et al
    Acute chest syndrome in adult patients with sickle cell disease: The relationship with the time to onset after hospital admission.
    Br J Haematol. 2023;201:1229-1238.
    >> Share

  78. JARISCH A, Salzmann-Manrique E, Soerensen J, Sach G, et al
    Donor-type red blood cell transfusion to deplete isoagglutinins prior to allogeneic stem cell transplantation from ABO major incompatible bone marrow donors.
    Br J Haematol. 2023;201:1159-1168.
    >> Share

    May 2023
  79. GAVILLET M, Rufer N, Grandoni F, Rizzi M, et al
    Successful outcome of pregnancy post-allogeneic stem cell transplant despite severe RH1 alloimmunization: A case report.
    Br J Haematol. 2023;201:581-584.
    >> Share

  80. PICCIN A, Magzoub I, Hervig T
    The 'scintilla' starting vaso-occlusion in sickle cell disease.
    Br J Haematol. 2023;201:379-380.
    >> Share

  81. AN R, Man Y, Cheng K, Zhang T, et al
    Sickle red blood cell-derived extracellular vesicles activate endothelial cells and enhance sickle red cell adhesion mediated by von Willebrand factor.
    Br J Haematol. 2023;201:552-563.
    >> Share

  82. TOWERMAN AS, Guilliams KP, Guerriero R, Shinawi MS, et al
    Hyperammonemia and acute liver failure associated with deferasirox in two adolescents with sickle cell disease.
    Br J Haematol. 2023;201:e30-e33.
    >> Share

  83. LUNATI-ROZIE A, Janin A, Faubert E, Nony S, et al
    Use of minigene assays as a useful tool to confirm the pathogenic role of intronic variations of the ANK1 gene: Report of two cases of hereditary spherocytosis.
    Br J Haematol. 2023;201:e46-e49.
    >> Share

  84. TENNENBAUM J, Volle G, Pouchot J, Joseph L, et al
    Increased risk of venous thromboembolism in splenectomized patients with sickle cell disease.
    Br J Haematol. 2023;201:793-796.
    >> Share

    April 2023
  85. SICA M, Barone F, Nannelli C, Ricci P, et al
    The long-acting anti-C5 ravulizumab results in C3 binding to PNH red cells similar to its parental molecule eculizumab.
    Br J Haematol. 2023;201:e1-e4.
    >> Share

  86. KAPUR R
    The potential of metabolomics as a predictive guide for clinical management in autoimmunity against red blood cells.
    Br J Haematol. 2023;201:13-14.
    >> Share

  87. ROSSI M, Pirenne F, Le Roux E, Smaine D, et al
    Delayed haemolytic transfusion reaction in paediatric patients with sickle cell disease: A retrospective study in a French national reference centre.
    Br J Haematol. 2023;201:125-132.
    >> Share

  88. WANG YM, Loveless M, Miller E, Nelson AS, et al
    Phenotypes of adults with Fanconi anaemia.
    Br J Haematol. 2023;201:133-139.
    >> Share

  89. RABELO IB, Chiba AK, Moritz E, D'Amora P, et al
    Metabolomic profile in patients with primary warm autoimmune haemolytic anaemia.
    Br J Haematol. 2023;201:140-149.
    >> Share

  90. JACOB M, Kawadler JM, Murdoch R, Ahmed M, et al
    Brain volume in Tanzanian children with sickle cell anaemia: A neuroimaging study.
    Br J Haematol. 2023;201:114-124.
    >> Share

  91. KOREN A
    The continuing global challenges of treating patients with beta-thalassemia.
    Br J Haematol. 2023;201:183-184.
    >> Share

  92. JACOBS JW, Binns TC, Abels E, Tormey CA, et al
    Autoimmune haemolytic anaemia secondary to babesiosis: A review of reported cases and description of a novel association with cold antibody-mediated haemolytic anaemia.
    Br J Haematol. 2023;201:364-369.
    >> Share

  93. SUTRA DEL GALY A, Willems L, D'Aveni M, Pautas C, et al
    Haemolytic paroxysmal nocturnal haemoglobinuria in patients with myeloid neoplasms: A rare association with specific therapeutic implications.
    Br J Haematol. 2023;201:e16-e20.
    >> Share

  94. HOKLAND P, Daar S, Khair W, Sheth S, et al
    Thalassaemia-A global view.
    Br J Haematol. 2023;201:199-214.
    >> Share

  95. DONZE C, Benoit A, Thuret I, Faust C, et al
    beta-Thalassemia in childhood: Current state of health in a high-income country.
    Br J Haematol. 2023;201:334-342.
    >> Share

  96. EARLEY EJ, Kelly S, Fang F, Alencar CS, et al
    Genome-wide association study of early ischaemic stroke risk in Brazilian individuals with sickle cell disease implicates ADAMTS2 and CDK18 and uncovers novel loci.
    Br J Haematol. 2023;201:343-352.
    >> Share

  97. JACOBS JW, Booth GS, Guarente J, Schlafer D, et al
    Autoimmune haemolytic anaemia and immune thrombocytopenia following SARS-CoV-2 and non-SARS-CoV-2 vaccination: 32 Years of passive surveillance data.
    Br J Haematol. 2023;201:227-233.
    >> Share

    March 2023
  98. IBEMERE SO, Oyedeji CI, Preiss L, Van Althuis LE, et al
    Characterising the prevalence of overweight and obese status among adults with sickle cell disease.
    Br J Haematol. 2023;200:633-642.
    >> Share

  99. JOSEPH L, Corbasson A, Manceau S, Khimoud D, et al
    Safety of coronavirus disease 2019 vaccines in 213 adult patients with sickle cell disease.
    Br J Haematol. 2023;200:563-567.
    >> Share

  100. TSITSIKAS DA, Rowe S, Bosch A, Hui C, et al
    Addition of plasma exchange to red cell exchange improves outcomes of fat embolism syndrome in sickle cell disease.
    Br J Haematol. 2023;200:e50-e52.
    >> Share

  101. MCKEAGUE S, Peake N, Lovelock D, Chow J, et al
    Acquired HbH disease diagnosed by HbA1c capillary electrophoresis.
    Br J Haematol. 2023;200:687.
    >> Share

  102. KOEHL B, Claude L, Reminy K, Tarer V, et al
    Erythrocyte type 1 equilibrative nucleoside transporter expression in sickle cell disease and sickle cell trait.
    Br J Haematol. 2023;200:812-820.
    >> Share

    February 2023
  103. POUTREL S, Boisson C, Nader E, Renoux C, et al
    Clinical severity and blood rheology in patients with sickle cell anaemia and co-existing autoimmune disease.
    Br J Haematol. 2023;200:e28-e31.
    >> Share

  104. AGUWA CJ, Cannon AD, Casella JF, Shapiro BK, et al
    Current developmental screening practices in young children with sickle cell disease.
    Br J Haematol. 2023;200:377-380.
    >> Share

  105. HEITZER AM, Schreiber JE, Yuan X, Wang F, et al
    Working memory and school readiness in preschool children with sickle cell disease compared to demographically matched controls.
    Br J Haematol. 2023;200:358-366.
    >> Share

  106. HU J, Gong S, Chen K, Yang R, et al
    Haploidentical transplant for paediatric patients with severe thalassaemia using post-transplant cyclophosphamide and methotrexate: A prospectively registered multicentre trial from the Bone Marrow Failure Working Group of Hunan Province, China.
    Br J Haematol. 2023;200:329-337.
    >> Share

  107. SIRIWORADETKUN S, Thiengtavor C, Thubthed R, Paiboonsukwong K, et al
    A comprehensive study of immune function and immunophenotyping of white blood cells from beta-thalassaemia/HbE patients on hydroxyurea supports the safety of the drug.
    Br J Haematol. 2023;200:367-376.
    >> Share

  108. RICCHI P
    Liver fibrosis in young patients with transfusion-dependent thalassaemia (TDT), understanding the role of steatosis.
    Br J Haematol. 2023;200:399-400.
    >> Share

  109. PADENIYA P, Ediriweera D, De Silva AP, Niriella M, et al
    The association between steatosis and liver damage in transfusion-dependent beta thalassaemia patients.
    Br J Haematol. 2023;200:517-523.
    >> Share

    January 2023
  110. NGUYEN PC, Tiong IS, Westerman DA, Blombery P, et al
    A novel ATRX variant with splicing consequences in myelodysplastic syndrome with acquired alpha thalassaemia.
    Br J Haematol. 2023;200:e13-e16.
    >> Share

  111. ZHU D, Liang G, Zhang Y, Wei X, et al
    Identification of haemolytic anaemia caused by glucose phosphate isomerase deficiency in a thalassaemia-endemic region: Correction of misdiagnosis and consideration of the cause of misdiagnosis.
    Br J Haematol. 2023;200:e8-e12.
    >> Share

  112. MOISE KJ JR
    Immunomodulation for early-onset haemolytic disease of the fetus/newborn: Can we delay the need for intrauterine transfusions?
    Br J Haematol. 2023;200:11-12.
    >> Share

  113. WILSON J
    Rasburicase-induced methaemoglobinaemia and catastrophic oxidative haemolysis in undiagnosed G6PD deficiency.
    Br J Haematol. 2023;200:7.
    >> Share

  114. VAN DIJK MJ, van Oirschot BA, Stam-Slob MC, Waanders E, et al
    Heterozygosity for bisphosphoglycerate mutase deficiency expressing clinically as congenital erythrocytosis: A case series and literature review.
    Br J Haematol. 2023;200:249-255.
    >> Share

    December 2022
  115. ZAMAN BA, Rasool SO, Abdo JM
    The effect of erythroferrone suppression by transfusion on the erythropoietin-erythroferrone-hepcidin axis in transfusion-dependent thalassaemia: A pre-post cohort study.
    Br J Haematol. 2022 Dec 19. doi: 10.1111/bjh.18619.
    >> Share

  116. LI M, Liu L, Ding B, Song X, et al
    Refractory/relapse thrombocytopenia in a patient with Evans' syndrome successfully treated with zanubrutinib.
    Br J Haematol. 2022;199:e37-e42.
    >> Share

  117. WINER JC, Yee ME, Ataga KI, Lebensburger JD, et al
    Patients with sickle cell disease who develop end-stage kidney disease continue to experience poor survival - A 19-year United States Renal Data System study.
    Br J Haematol. 2022;199:e43-e47.
    >> Share

  118. DE LA IGLESIA INIGO S, Navarrete Bullon L, Stuckey R, Veiga Vaz A, et al
    Cauda equina syndrome secondary to extramedullary erythropoiesis in a transfusion-dependent thalassemia patient following treatment with luspatercept: A case report.
    Br J Haematol. 2022;199:e30-e33.
    >> Share

  119. RAJPUT RV, Ma X, Boswell KL, Gaudinski M, et al
    Clinical outcomes and immune responses to SARS-CoV-2 vaccination in severe aplastic anaemia.
    Br J Haematol. 2022;199:679-687.
    >> Share

  120. CONNELLY JA, Savani BN
    Irradiation-free, T-cell replete haploidentical transplant for Fanconi anaemia, weighing the benefits.
    Br J Haematol. 2022;199:639-641.
    >> Share

  121. VIAL Y, Lainey E, Leblanc T, Baudouin V, et al
    De novo NUF2 variant in a novel inherited bone marrow failure syndrome including microcephaly and renal hypoplasia.
    Br J Haematol. 2022;199:739-743.
    >> Share

    November 2022
  122. AMPOMAH MA, Drake JA, Anum A, Amponsah B, et al
    A case-control and seven-year longitudinal neurocognitive study of adults with sickle cell disease in Ghana.
    Br J Haematol. 2022;199:411-426.
    >> Share

  123. XU L, Lu Y, Hu S, Li C, et al
    Unmanipulated haploidentical haematopoietic cell transplantation with radiation-free conditioning in Fanconi anaemia: A retrospective analysis from the Chinese Blood and Marrow Transplantation Registry Group.
    Br J Haematol. 2022;199:401-410.
    >> Share

  124. HAN J, Zhang X, Molokie RE, Njoku FU, et al
    COVID-19 vaccination status and disease burden in patients with sickle cell disease.
    Br J Haematol. 2022;199:e21-e24.
    >> Share

  125. OGUNSILE FJ, Stewart KJ, Kanter J, Lanzkron SM, et al
    An evaluation of cardiopulmonary endurance and muscular strength in adults living with sickle cell disease.
    Br J Haematol. 2022;199:597-602.
    >> Share

  126. RODRIGUEZ CORTE J, Candal-Pedreira C, Ruano-Ravina A, Perez-Rios M, et al
    Home-based blood transfusion therapy: A systematic review.
    Br J Haematol. 2022;199:496-506.
    >> Share

    October 2022
  127. TORTI L
    Life beyond alpha-thalassaemia: We are moving forward.
    Br J Haematol. 2022;199:11-13.
    >> Share

  128. PAALVAST Y, Moazzen S, Sweegers M, Hogema B, et al
    A computational model for prediction of ferritin and haemoglobin levels in blood donors.
    Br J Haematol. 2022;199:143-152.
    >> Share

  129. CONRAN N, de Alvarenga Maximo C, Oliveira T, Fertrin KY, et al
    Safe use of hydroxycarbamide in sickle cell disease patients hospitalized for painful vaso-occlusive episodes during the randomized, open-label HELPS study.
    Br J Haematol. 2022;199:153-157.
    >> Share

  130. AKE-SITTIPAISARN S, Sirichotiyakul S, Srisupundit K, Luewan S, et al
    Outcomes of pregnancies complicated by haemoglobin H-constant spring and deletional haemoglobin H disease: A retrospective cohort study.
    Br J Haematol. 2022;199:122-129.
    >> Share

  131. EYSSETTE-GUERREAU S, Khimoud D, Michaux K, Odievre MH, et al
    Severe cases of COVID-19 in children with sickle cell disease during the Omicron wave in France: a plea for vaccination.
    Br J Haematol. 2022;199:e8-e11.
    >> Share

  132. ESPERTI S, Boisson C, Robert M, Nader E, et al
    Does G6PD deficiency cause further damage to red blood cells of patients with sickle cell anaemia?
    Br J Haematol. 2022;199:289-291.
    >> Share

  133. QUARELLO P, Ramenghi U, Fagioli F
    Diamond-Blackfan anaemia with iron overload: A serious issue.
    Br J Haematol. 2022;199:171-172.
    >> Share

  134. CHURCHILL D, Ali H, Moussa M, Donohue C, et al
    Maternal iron deficiency anaemia in pregnancy: Lessons from a national audit.
    Br J Haematol. 2022;199:277-284.
    >> Share

  135. LECORNEC N, Castex MP, Reguerre Y, Moreau P, et al
    Agranulocytosis in patients with Diamond-Blackfan anaemia (DBA) treated with deferiprone for post-transfusion iron overload: A retrospective study of the French DBA cohort.
    Br J Haematol. 2022;199:285-288.
    >> Share

    September 2022
  136. WULFTANGE WJ, Kucukal E, Man Y, An R, et al
    Antithrombin-III mitigates thrombin-mediated endothelial cell contraction and sickle red blood cell adhesion in microscale flow.
    Br J Haematol. 2022;198:893-902.
    >> Share

  137. CORNELISSEN HM, Musekwa EM, Glashoff RH, Esser M, et al
    Peripheral-blood cytopenia, an early indicator of inborn errors of immunity.
    Br J Haematol. 2022;198:875-886.
    >> Share

  138. ALIBERTI L, Gagliardi I, Gamberini MR, Ziggiotto A, et al
    Beta-thalassaemia major: Prevalence, risk factors and clinical consequences of hypercalciuria.
    Br J Haematol. 2022;198:903-911.
    >> Share

  139. ARITA K, Murakami J, Iwaki N, Hosono N, et al
    An eltrombopag-induced remission of bone-marrow aplasia accompanied by marked leukoerythroblastosis and splenomegaly.
    Br J Haematol. 2022;198:e75-e77.
    >> Share

  140. PATEL NG, Young D, Numan Y, Bhasin A, et al
    The utility of peripheral blood film and haemolysis markers in evaluation of haemolytic anaemia at a tertiary care hospital.
    Br J Haematol. 2022;198:927-929.
    >> Share

  141. VERCELLATI C, Zaninoni A, Marcello AP, Fermo E, et al
    Changing trends of splenectomy in hereditary spherocytosis: The experience of a reference Centre in the last 40 years.
    Br J Haematol. 2022;198:912-915.
    >> Share

  142. TANTRAVAHI SK, Huber BD, Vagher J, Maese L, et al
    Genome-wide uniparental disomy as a mechanism of immune escape in acquired aplastic anaemia.
    Br J Haematol. 2022;198:e78-e81.
    >> Share

  143. SONGDEJ D, Kadegasem P, Tangbubpha N, Sasanakul W, et al
    Whole-exome sequencing uncovered genetic diagnosis of severe inherited haemolytic anaemia: Correlation with clinical phenotypes.
    Br J Haematol. 2022;198:1051-1064.
    >> Share

    August 2022
  144. WILSON J
    Unlikely bedfellows - Sickle cells with malaria parasites.
    Br J Haematol. 2022 Aug 12. doi: 10.1111/bjh.18412.
    >> Share

  145. MORICONI C, Dzieciatkowska M, Roy M, D'Alessandro A, et al
    Retention of functional mitochondria in mature red blood cells from patients with sickle cell disease.
    Br J Haematol. 2022;198:574-586.
    >> Share

  146. ROY NBA, Da Costa L, Russo R, Bianchi P, et al
    The use of next-generation sequencing in the diagnosis of rare inherited anaemias: A Joint BSH/EHA Good Practice Paper.
    Br J Haematol. 2022;198:459-477.
    >> Share

  147. NISHIMURA JI, Usuki K, Ramos J, Ichikawa S, et al
    Crovalimab for treatment of patients with paroxysmal nocturnal haemoglobinuria and complement C5 polymorphism: Subanalysis of the phase 1/2 COMPOSER study.
    Br J Haematol. 2022;198:e46-e50.
    >> Share

  148. GAARTMAN AE, Strijdhorst A, van Es N, Tang MW, et al
    Limited value of the D-dimer based YEARS algorithm to rule out pulmonary embolism in sickle cell disease and sickle cell trait.
    Br J Haematol. 2022;198:e42-e45.
    >> Share

  149. GREEN NS, Van Doren L, Licursi M, Billings DD, et al
    Anti-SARS-CoV-19 antibodies in children and adults with sickle cell disease: A single-site analysis in New York City.
    Br J Haematol. 2022;198:680-683.
    >> Share

  150. SHARMA A, Leonard A, West K, Gossett JM, et al
    Optimizing haematopoietic stem and progenitor cell apheresis collection from plerixafor-mobilized patients with sickle cell disease.
    Br J Haematol. 2022;198:740-744.
    >> Share

  151. URSULE-DUFAIT C, Bengoufa D, Theodorou I, Villesuzanne C, et al
    Heavy chain/light chain assay is a useful biomarker for diagnosis and management of patients with cold agglutinin disease.
    Br J Haematol. 2022;198:e67-e70.
    >> Share

  152. OGBENNA AA, Akinsete AM, Kalejaiye OO, Matthew OK, et al
    Reduction in seroprevalence of viral transfusion-transmitted infections in southwest Nigeria in children with sickle cell disease using an enhanced screening strategy.
    Br J Haematol. 2022;198:745-752.
    >> Share

  153. GELBENEGGER G, Jaeger U, Fillitz M, D'Sa S, et al
    Sustained sutimlimab response for 3 years in patients with cold agglutinin disease: A phase I, open-label, extension trial.
    Br J Haematol. 2022;198:e59-e62.
    >> Share

    July 2022
  154. SCOTT C, Bartolovic K, Clark SA, Waithe D, et al
    Functional impairment of erythropoiesis in Congenital Dyserythropoietic Anaemia type I arises at the progenitor level.
    Br J Haematol. 2022;198:e10-e14.
    >> Share

  155. COOPER-SOOD JB, Hagar W, Marsh A, Hoppe C, et al
    Adjuvant low-dose ketamine for paediatric and young adult sickle cell vaso-occlusive episodes in the emergency department.
    Br J Haematol. 2022;198:207-209.
    >> Share

  156. BUESCHE G, Teoman H, Schneider RK, Ribezzo F, et al
    Evolution of severe (transfusion-dependent) anaemia in myelodysplastic syndromes with 5q deletion is characterized by a macrophage-associated failure of the eythropoietic niche.
    Br J Haematol. 2022;198:114-130.
    >> Share

  157. CAUGHEY MC, Derebail VK, Carden MA, Novelli EM, et al
    Prevalence and outcomes of dehydration in adults with sickle cell trait: the Atherosclerosis Risk in Communities (ARIC) study.
    Br J Haematol. 2022;198:397-400.
    >> Share

  158. GUO JJ, Cao L, Zhu HY, Miao Y, et al
    T-cell large granular lymphocytic leukaemia with atypical immunophenotypes: A single-centre retrospective analysis of 17 cases.
    Br J Haematol. 2022;198:e18-e22.
    >> Share

  159. KONGKIATKAMON S
    Acute haemolysis following COVID-19 vaccination in a thalassaemic patient with G6PD deficiency.
    Br J Haematol. 2022;198:221.
    >> Share

  160. EARLY ML, Linton E, Bosch A, Campbell T, et al
    The Montreal cognitive assessment as a cognitive screening tool in sickle cell disease: Associations with clinically significant cognitive domains.
    Br J Haematol. 2022;198:382-390.
    >> Share

    June 2022
  161. DELAPORTA P, Terpos E, Solomou EE, Gumeni S, et al
    Immune response and adverse events after vaccination against SARS-CoV-2 in adult patients with transfusion-dependent thalassaemia.
    Br J Haematol. 2022;197:576-579.
    >> Share

  162. PICCIN A, O'Connor-Byrne N, Daves M, Lynch K, et al
    Autoimmune disease and sickle cell anaemia: 'Intersecting pathways and differential diagnosis'.
    Br J Haematol. 2022;197:518-528.
    >> Share

  163. HAN J, Molokie RE, Hussain F, Njoku F, et al
    Voxelotor and albuminuria in adults with sickle cell anaemia.
    Br J Haematol. 2022;197:e63-e64.
    >> Share

  164. SHEEHAN VA, van Beers EJ, Connes P, van Wijk R, et al
    Comment on: Oxygen gradient ektacytometry does not predict pain in children with sickle cell anaemia.
    Br J Haematol. 2022;197:e61-e62.
    >> Share

  165. JOLY P, Boisson C, Renoux C, Caillat N, et al
    Determinants of the point of sickling measured by oxygen gradient ektacytometry in sickle cell anaemia.
    Br J Haematol. 2022;197:e56-e58.
    >> Share

  166. NARDO-MARINO A, Petersen J, Brewin JN, Birgens H, et al
    Oxygen gradient ektacytometry does not predict pain in children with sickle cell anaemia.
    Br J Haematol. 2022;197:609-617.
    >> Share

  167. MARSHALL WH 5TH, Cleary EM, Della-Moretta S, Li R, et al
    Elevated tricuspid regurgitation velocity is associated with increased adverse haematologic events during pregnancy in women with sickle cell disease.
    Br J Haematol. 2022;197:795-801.
    >> Share

    May 2022
  168. AMID A, Barrowman N, Odame I, Kirby-Allen M, et al
    Optimizing transfusion therapy for survivors of Haemoglobin Bart's hydrops fetalis syndrome: Defining the targets for haemoglobin-H fraction and "functional" haemoglobin level.
    Br J Haematol. 2022;197:373-376.
    >> Share

  169. LONGORIA JN, Heitzer AM, Hankins JS, Trpchevska A, et al
    Neurocognitive risk in sickle cell disease: Utilizing neuropsychology services to manage cognitive symptoms and functional limitations.
    Br J Haematol. 2022;197:260-270.
    >> Share

  170. BAIN BJ, Littlewood T, Rees DC
    What does the term 'sickle cell disease' mean?
    Br J Haematol. 2022;197:381-382.
    >> Share

  171. ALTER BP, Giri N, McReynolds LJ, Altintas B, et al
    Fanconi anaemia: A syndrome with distinct subgroups.
    Br J Haematol. 2022;197:467-474.
    >> Share

  172. VORA SM, Boyd S, Denny N, Jackson E, et al
    Expanded eligibility for emerging therapies in sickle cell disease in the UK - crizanlizumab and voxelotor.
    Br J Haematol. 2022;197:502-504.
    >> Share

    April 2022
  173. TANIGUCHI T, Nakayama S, Tanaka H, Rai S, et al
    Novel prognostic predictor of haemoglobin-platelet index in diffuse large B-cell lymphoma, not otherwise specified: Anaemia and thrombocytopenia are associated with IL-6 production in lymphoma cells.
    Br J Haematol. 2022 Apr 22. doi: 10.1111/bjh.18208.
    >> Share

  174. SUN Y, Habara A, Le CQ, Nguyen N, et al
    Pharmacologic induction of PGC-1alpha stimulates fetal haemoglobin gene expression.
    Br J Haematol. 2022;197:97-109.
    >> Share

  175. RIEU JB, Largeaud L, Da Costa L, Cougoul P, et al
    Unexplained iron overload with haemolytic anaemia should prompt looking for morphological changes in erythroid precursors.
    Br J Haematol. 2022;197:132.
    >> Share

  176. ROSS DM
    Iron chelation for myelofibrosis-related anaemia during treatment with a Janus kinase inhibitor.
    Br J Haematol. 2022;197:135-136.
    >> Share

  177. GARG M, Agarwal S, Altohami M
    A single dose of eculizumab terminated life-threatening haemolysis in idiopathic IgM-mediated warm autoimmune haemolytic anaemia: A case report.
    Br J Haematol. 2022;197:e28-e31.
    >> Share

  178. BATISTA THC, Santana RM, Sobreira MJ, Arcanjo GS, et al
    Up-regulation of miR-130a is related to leg ulcers in sickle cell anaemia.
    Br J Haematol. 2022;197:e16-e18.
    >> Share

  179. TORRES LS, Teles LIM, Shaul ME, Fridlender ZG, et al
    Accelerated low-density neutrophil transition in sickle cell anaemia may contribute to disease pathophysiology.
    Br J Haematol. 2022;197:232-235.
    >> Share

    March 2022
  180. MIODOWNIK H, Curtis SA, Olivia Ogu U, Bradford C, et al
    Frequent health care utilisation and avascular necrosis are associated with cannabis use in adults with sickle cell disease.
    Br J Haematol. 2022;196:e41-e44.
    >> Share

  181. CECCHI N, Giannotta JA, Barcellini W, Fattizzo B, et al
    A case of severe aplastic anaemia after SARS-CoV-2 vaccination.
    Br J Haematol. 2022;196:1334-1336.
    >> Share

  182. CONSTANTINOU V, Papayanni PG, Mallouri D, Batsis I, et al
    Case study of betibeglogene autotemcel gene therapy in an adult Greek patient with transfusion-dependent beta-thalassaemia of a severe genotype.
    Br J Haematol. 2022;196:1401-1404.
    >> Share

  183. CHARNAY T, Cerino M, Gonnet K, Bonello-Palot N, et al
    A novel SUPT5H variant associated with a beta-thalassaemia trait.
    Br J Haematol. 2022;196:e70-e71.
    >> Share

  184. TAMURA S, Hori Y, Hiroi T, Morimoto M, et al
    Pegcetacoplan for refractory paroxysmal nocturnal haemoglobinuria associated with the C5 genetic variant.
    Br J Haematol. 2022;196:e57-e60.
    >> Share

    February 2022
  185. RUND D
    Laboratory diagnosis of iron deficiency: look out for the 'PITTs'.
    Br J Haematol. 2022;196:464-465.
    >> Share

  186. XU LP, Yu Y, Cheng YF, Zhang YY, et al
    Development and validation of a mortality predicting scoring system for severe aplastic anaemia patients receiving haploidentical allogeneic transplantation.
    Br J Haematol. 2022;196:735-742.
    >> Share

  187. FLETCHER A, Forbes A, Svenson N, Wayne Thomas D, et al
    Guideline for the laboratory diagnosis of iron deficiency in adults (excluding pregnancy) and children.
    Br J Haematol. 2022;196:523-529.
    >> Share

  188. POPLAWSKA M, Dutta D, Jayaram M, Salifu M, et al
    Intestinal pathophysiological abnormalities in steady state and after vaso-occlusive crisis in murine sickle cell disease.
    Br J Haematol. 2022;196:777-780.
    >> Share

  189. GERRITSMA J, Bongaerts V, Eckhardt C, Heijboer H, et al
    Extended phenotyping does not preclude the occurrence of delayed haemolytic transfusion reactions in sickle cell disease.
    Br J Haematol. 2022;196:769-776.
    >> Share

  190. BARADE A, Aboobacker F, Korula A, Lakshmi K, et al
    Impact of donor telomere length on survival in patients undergoing matched sibling donor transplantation for aplastic anaemia.
    Br J Haematol. 2022;196:724-734.
    >> Share

  191. MAGGIO A
    Cell erythroid maturation approach: a new paradigm in the road map towards a cure for beta-thalassaemia syndromes.
    Br J Haematol. 2022;196:806-808.
    >> Share

  192. OAKLEY LL, Mitchell S, von Rege I, Hadebe R, et al
    Perinatal outcomes in women with sickle cell disease: a matched cohort study from London, UK.
    Br J Haematol. 2022;196:1069-1075.
    >> Share

  193. VLACHODIMITROPOULOU E, Garbowski M, Anne Solomon S, Abbasi N, et al
    Outcome predictors for maternal red blood cell alloimmunisation with anti-K and anti-D managed with intrauterine blood transfusion.
    Br J Haematol. 2022;196:1096-1104.
    >> Share

  194. JONASSAINT CR, Lukombo I, Feldman R, Driscoll J, et al
    Differences in the prevalence of mental health disorders among Black American adults with sickle cell disease compared to those with non-heritable medical conditions or no medical conditions.
    Br J Haematol. 2022;196:1059-1068.
    >> Share

  195. WHITE J, Callaghan MU, Gao X, Liu K, et al
    Longitudinal assessment of adhesion to vascular cell adhesion molecule-1 at steady state and during vaso-occlusive crises in sickle cell disease.
    Br J Haematol. 2022;196:1052-1058.
    >> Share

  196. TANEJA K, Verma C, Mahajan A
    Can ruxolitinib avert splenectomy in patients with thalassaemia: a short term case series.
    Br J Haematol. 2022;196:1111-1113.
    >> Share

  197. VENUGOPAL J, Wang J, Guo C, Eitzman DT, et al
    Interleukin-1 receptor antagonism leads to improved anaemia in a murine model of sickle cell disease and is associated with reduced ex vivo platelet-mediated erythrocyte sickling.
    Br J Haematol. 2022;196:1040-1051.
    >> Share

    January 2022
  198. NAVILLE AS, Lazaro E, Boutin J, Prot-Leurent C, et al
    Acquired glucose 6-phosphate dehydrogenase (G6PD) deficiency in a patient with Chronic Myelomonocytic Leukemia.
    Br J Haematol. 2022 Jan 6. doi: 10.1111/bjh.18037.
    >> Share

  199. BRODSKY RA, Lee JW, Nishimura JI, Szer J, et al
    Lactate dehydrogenase versus haemoglobin: which one is the better marker in paroxysmal nocturnal haemoglobinuria?
    Br J Haematol. 2022;196:264-265.
    >> Share

  200. RUND D
    A Paradigm shift in genotype-phenotype relationships in beta-thalassaemia.
    Br J Haematol. 2022;196:270-271.
    >> Share

  201. ROY NBA
    Iron overload in inherited anaemias: why one size can't fit all.
    Br J Haematol. 2022;196:266-267.
    >> Share

  202. SMITH WR, McClish DK, Lottenberg R, Sisler IY, et al
    A randomised controlled provider-blinded trial of community health workers in sickle cell anaemia: effects on haematologic variables and hydroxyurea adherence.
    Br J Haematol. 2022;196:193-203.
    >> Share

  203. CHAPIN J, Cohen AR, Neufeld EJ, Vichinsky E, et al
    An update on the US adult thalassaemia population: a report from the CDC thalassaemia treatment centres.
    Br J Haematol. 2022;196:380-389.
    >> Share

  204. MUSALLAM KM, Vitrano A, Meloni A, Addario Pollina S, et al
    Primary HBB gene mutation severity and long-term outcomes in a global cohort of beta-thalassaemia.
    Br J Haematol. 2022;196:414-423.
    >> Share

  205. SHAH FT, Porter JB, Sadasivam N, Kaya B, et al
    Guidelines for the monitoring and management of iron overload in patients with haemoglobinopathies and rare anaemias.
    Br J Haematol. 2022;196:336-350.
    >> Share

  206. CHEN N, Li Z, Huang Y, Xiao C, et al
    Iron parameters in pregnant women with beta-thalassaemia minor combined with iron deficiency anaemia compared to pregnant women with iron deficiency anaemia alone demonstrate the safety of iron supplementation in beta-thalassaemia minor during pregnan
    Br J Haematol. 2022;196:390-396.
    >> Share

  207. KIENZLE SL, Rodeghier M, Liem RI
    Heart rate variability associated with acute exercise challenge in children with sickle cell anaemia.
    Br J Haematol. 2022;196:397-401.
    >> Share

  208. ADEBAYO OC, Betukumesu DK, Nkoy AB, Adesoji OM, et al
    Clinical and genetic factors are associated with kidney complications in African children with sickle cell anaemia.
    Br J Haematol. 2022;196:204-214.
    >> Share

  209. GRIFFIN R, Panayiotou A, Allen P, Height S, et al
    What is the role of chest X-ray imaging in the acute management of children with sickle cell disease?
    Br J Haematol. 2022;196:402-413.
    >> Share

  210. COLMAN KS, Pavord S, Roy N
    A quality improvement project for the cost-effective management of maternal anaemia.
    Br J Haematol. 2022;196:445-448.
    >> Share

  211. VASSEUR C, Domingues-Hamdi E, Pakdaman S, Galacteros F, et al
    Alpha haemoglobin-stabilising protein concentration in the red blood cells of patients with sickle cell anaemia with and without hydroxycarbamide treatment.
    Br J Haematol. 2022;196:183-192.
    >> Share

  212. RISITANO AM, Peffault de Latour R
    How we('ll) treat paroxysmal nocturnal haemoglobinuria: diving into the future.
    Br J Haematol. 2022;196:288-303.
    >> Share

  213. DEXTER D, McGann PT
    Saving lives through early diagnosis: the promise and role of point of care testing for sickle cell disease.
    Br J Haematol. 2022;196:63-69.
    >> Share

  214. MANABE M, Hagiwara Y, Asada R, Tanizawa N, et al
    Acquired elliptocytosis in a patient with myelodysplastic syndrome harbouring a novel unbalanced whole-arm translocation, der(14;20)(q10;p10).
    Br J Haematol. 2022;196:7.
    >> Share

  215. BARRITEAU CM, Chiu A, Rodeghier M, Liem RI, et al
    Cerebral and skeletal muscle tissue oxygenation during exercise challenge in children and young adults with sickle cell anaemia.
    Br J Haematol. 2022;196:179-182.
    >> Share

  216. HUGHES AD, Kurre P
    The impact of clonal diversity and mosaicism on haematopoietic function in Fanconi anaemia.
    Br J Haematol. 2022;196:274-287.
    >> Share

  217. GABELLI M, Ademokun C, Cooper N, Amrolia PI, et al
    Pathogenesis, risk factors and therapeutic options for autoimmune haemolytic anaemia in the post-transplant setting.
    Br J Haematol. 2022;196:45-62.
    >> Share

    December 2021
  218. AOUN SA, Motabi I
    Cold agglutinin disease after COVID-19 vaccine.
    Br J Haematol. 2021;195:650.
    >> Share

  219. LIN J, Ye Y, Shang X, Zhang Y, et al
    TEA domain transcription factor 4 modulates repression of fetal haemoglobin by direct binding to the gamma-globin gene promoters.
    Br J Haematol. 2021;195:764-769.
    >> Share

  220. NAKAGAWA N, Ishiyama K, Tanabe M, Yoroidaka T, et al
    The effectiveness of immunosuppressive therapy in patients with aplastic anaemia secondary to chemoradiotherapy for cancers.
    Br J Haematol. 2021;195:770-780.
    >> Share

  221. BADAWY SM, Payne AB, Hulihan MM, Coates TD, et al
    Concordance with comprehensive iron assessment, hepatitis A vaccination, and hepatitis B vaccination recommendations among patients with sickle cell disease and thalassaemia receiving chronic transfusions: an analysis from the Centers for Disease Cont
    Br J Haematol. 2021;195:e160-e164.
    >> Share

  222. WILSON SR, Sears M, Williams E, Drapekin J, et al
    Gaps in the diagnosis and management of iron overload in sickle cell disease: a 'real-world' report from the GRNDaD registry.
    Br J Haematol. 2021;195:e157-e160.
    >> Share

    November 2021
  223. HALL R, Meenan J, Mihalca D, Katumba A, et al
    The real impact of COVID-19 on an East London Sickle cell population: results of a service-wide survey.
    Br J Haematol. 2021;195:532-535.
    >> Share

  224. LILES DK, Shah NR, Scullin B, Gordeuk VR, et al
    Long-term biological effects in sickle cell disease: insights from a post-crizanlizumab study.
    Br J Haematol. 2021;195:e150-e153.
    >> Share

  225. EL-AMIN N, Lauzon SD, Nietert PJ, Kanter J, et al
    Which adults with sickle cell disease need an evaluation for pulmonary embolism?
    Br J Haematol. 2021;195:447-455.
    >> Share

  226. WANG W, Freeman M, Hamilton L, Carroll Y, et al
    Developmental screening of three-year-old children with sickle cell disease compared to controls.
    Br J Haematol. 2021;195:621-628.
    >> Share

  227. BOISSON C, Renoux C, Nader E, Gauthier A, et al
    Comparisons of oxygen gradient ektacytometry parameters between sickle cell patients with or without alpha-thalassaemia.
    Br J Haematol. 2021;195:629-633.
    >> Share

  228. LAFAURIE M, Maquet J, Baricault B, Ekstrand C, et al
    Risk factors of hospitalisation for thrombosis in adults with primary immune thrombocytopenia, including disease-specific treatments: a French nationwide cohort study.
    Br J Haematol. 2021;195:456-465.
    >> Share

  229. RANKINE-MULLINGS A, Reid M, Soares D, Taylor-Bryan C, et al
    Hydroxycarbamide treatment reduces transcranial Doppler velocity in the absence of transfusion support in children with sickle cell anaemia, elevated transcranial Doppler velocity, and cerebral vasculopathy: the EXTEND trial.
    Br J Haematol. 2021;195:612-620.
    >> Share

  230. BALLAS SK, Kuypers FA, Gordeuk VR, Hankins JS, et al
    Time to rethink haemoglobin threshold guidelines in sickle cell disease.
    Br J Haematol. 2021;195:518-522.
    >> Share

    October 2021
  231. HE Z, Sun X, Wang S, Bai D, et al
    Ggct (gamma-glutamyl cyclotransferase) plays an important role in erythrocyte antioxidant defense and red blood cell survival.
    Br J Haematol. 2021;195:267-275.
    >> Share

  232. KARKOSKA K
    Neuroprotection: further evidence for the early and universal use of hydroxyurea in children with sickle cell disease.
    Br J Haematol. 2021;195:158-159.
    >> Share

  233. CAPPELLI B, Scigliuolo GM, Boukouaci W, Rafii H, et al
    Impact of the human leucocyte antigen (HLA)-B leader peptide dimorphism and HLA-A expression on outcomes of stem cell transplantation for sickle cell disease.
    Br J Haematol. 2021;195:e128-e131.
    >> Share

  234. HEITZER AM, Longoria J, Okhomina V, Wang WC, et al
    Hydroxyurea treatment and neurocognitive functioning in sickle cell disease from school age to young adulthood.
    Br J Haematol. 2021;195:256-266.
    >> Share

  235. DEREBAIL VK, Zhou Q, Ciccone EJ, Cai J, et al
    Longitudinal study of glomerular hyperfiltration and normalization of estimated glomerular filtration in adults with sickle cell disease.
    Br J Haematol. 2021;195:123-132.
    >> Share

    September 2021
  236. MASLAH N, Ravdan O, Drevon L, Verger E, et al
    Revisiting Diagnostic performances of serum erythropoietin level and JAK2 mutation for polycythemias: analysis of a cohort of 1090 patients with red cell mass measurement.
    Br J Haematol. 2021 Sep 25. doi: 10.1111/bjh.17848.
    >> Share

  237. BARCELLINI W, Fattizzo B, Giannotta JA, Quattrocchi L, et al
    COVID-19 in patients with paroxysmal nocturnal haemoglobinuria: an Italian multicentre survey.
    Br J Haematol. 2021;194:854-856.
    >> Share

  238. MUNARETTO V, Voi V, Palazzi G, Notarangelo LD, et al
    Acute events in children with sickle cell disease in Italy during the COVID-19 pandemic: useful lessons learned.
    Br J Haematol. 2021;194:851-854.
    >> Share

  239. HINES PC, Callaghan MU, Zaidi AU, Gao X, et al
    Flow adhesion of whole blood to P-selectin: a prognostic biomarker for vaso-occlusive crisis in sickle cell disease.
    Br J Haematol. 2021;194:1074-1082.
    >> Share

  240. OTENG-NTIM E, Pavord S, Howard R, Robinson S, et al
    Management of sickle cell disease in pregnancy. A British Society for Haematology Guideline.
    Br J Haematol. 2021;194:980-995.
    >> Share

  241. STRATTON P
    Standardizing care of those at great risk: the importance of sickle cell in pregnancy practice guidelines.
    Br J Haematol. 2021;194:950-953.
    >> Share

  242. GAARTMAN AE, Sayedi AK, Gerritsma JJ, de Back TR, et al
    Fluid overload due to intravenous fluid therapy for vaso-occlusive crisis in sickle cell disease: incidence and risk factors.
    Br J Haematol. 2021;194:899-907.
    >> Share

  243. PECKER LH, Sharma D, Nero A, Paidas MJ, et al
    Knowledge gaps in reproductive and sexual health in girls and women with sickle cell disease.
    Br J Haematol. 2021;194:970-979.
    >> Share

  244. RIEGER MJ, Stolz SM, Ludwig S, Benoit TM, et al
    Daratumumab in rituximab-refractory autoimmune haemolytic anaemia.
    Br J Haematol. 2021;194:931-934.
    >> Share

  245. BOUDHABHAY I, Boutin E, Bartolucci P, Bornes MI, et al
    Impact of pre-eclampsia on renal outcome in sickle cell disease patients.
    Br J Haematol. 2021;194:1053-1062.
    >> Share

  246. MALINOWSKI AK, Kuo KHM, Tomlinson GA, Palcu P, et al
    Distinct maternal and fetal pregnancy outcomes in women with sickle cell disease can be predicted using routine clinical and laboratory data.
    Br J Haematol. 2021;194:1063-1073.
    >> Share

  247. SARAF SL
    The vasculopathic cord between pre-eclampsia and kidney function in sickle cell disease.
    Br J Haematol. 2021;194:947-949.
    >> Share

  248. KUMKHAEK C, Uchida N, Tisdale JF, Rodgers GP, et al
    Comparison of CD34(+) cells isolated from frozen cord blood and fresh adult peripheral blood of sickle cell disease patients in gene correction of the sickle mutation at late-stage erythroid differentiation.
    Br J Haematol. 2021;194:e80-e84.
    >> Share

  249. GOTTGENS EL, Ligthart PC, Veldhuisen B, Veldthuis M, et al
    Rh-null phenotype and stomatocytosis.
    Br J Haematol. 2021;194:803.
    >> Share

  250. SCHEINBERG P
    Acquired severe aplastic anaemia: how medical therapy evolved in the 20th and 21st centuries.
    Br J Haematol. 2021;194:954-969.
    >> Share

    August 2021
  251. NJOKU F, Zhang X, Shah BN, Machado RF, et al
    Biomarkers of clinical severity in treated and untreated sickle cell disease: a comparison by genotypes of a single center cohort and African Americans in the NHANES study.
    Br J Haematol. 2021;194:767-778.
    >> Share

  252. ELSHERIF L, Scott LC, Wichlan D, Jones SK, et al
    Hydroxyurea therapy decreases coagulation and endothelial activation in sickle cell disease: a Longitudinal Study.
    Br J Haematol. 2021;194:e71-e73.
    >> Share

  253. QUINN CT, Niss O, Dong M, Pfeiffer A, et al
    Early initiation of hydroxyurea (hydroxycarbamide) using individualised, pharmacokinetics-guided dosing can produce sustained and nearly pancellular expression of fetal haemoglobin in children with sickle cell anaemia.
    Br J Haematol. 2021;194:617-625.
    >> Share

  254. TANGSRICHAROEN T, Natesirinilkul R, Phusua A, Fanhchaksai K, et al
    Severe neonatal haemolytic anaemia caused by compound heterozygous KLF1 mutations: report of four families and literature review.
    Br J Haematol. 2021;194:626-634.
    >> Share

    July 2021
  255. FATTIZZO B, Rizzo L, Giannotta JA, Mazzon F, et al
    Switching to an alternative recombinant erythropoietin agent in patients with myelodysplastic syndromes: a second honeymoon?
    Br J Haematol. 2021 Jul 26. doi: 10.1111/bjh.17722.
    >> Share

  256. KILLICK SB, Ingram W, Culligan D, Enright H, et al
    British Society for Haematology guidelines for the management of adult myelodysplastic syndromes.
    Br J Haematol. 2021;194:267-281.
    >> Share

  257. MITTELMAN M, Oster HS
    Thrombocytopenia in myelodysplastic syndromes: time to lift the embargo on thrombomimetics?
    Br J Haematol. 2021;194:231-233.
    >> Share

  258. RASHKIN SR, Rampersaud E, Kang G, Ataga KI, et al
    Generalization of a genetic risk score for time to first albuminuria in children with sickle cell anaemia: SCCRIP cohort study results.
    Br J Haematol. 2021;194:469-473.
    >> Share

  259. ESTEPP JH, Cong Z, Agodoa I, Kang G, et al
    What drives transcranial Doppler velocity improvement in paediatric sickle cell anaemia: analysis from the Sickle Cell Clinical Research and Intervention Program (SCCRIP) longitudinal cohort study.
    Br J Haematol. 2021;194:463-468.
    >> Share

  260. ALNAFIE AN, Alateeq SA, Al-Muhanna FA, Alsulaiman AM, et al
    Exome sequencing in high and low fetal haemoglobin Arab-Indian haplotype sickle cell disease.
    Br J Haematol. 2021;194:e61-e64.
    >> Share

  261. PERES L, Monedero Alonso D, Nudel M, Figeac M, et al
    Characterisation of Asp669Tyr Piezo1 cation channel activity in red blood cells: an unexpected phenotype.
    Br J Haematol. 2021;194:e51-e55.
    >> Share

  262. VADOLAS J, Ng GZ, Kysenius K, Crouch PJ, et al
    SLN124, a GalNac-siRNA targeting transmembrane serine protease 6, in combination with deferiprone therapy reduces ineffective erythropoiesis and hepatic iron-overload in a mouse model of beta-thalassaemia.
    Br J Haematol. 2021;194:200-210.
    >> Share

  263. TAHER AT, Viprakasit V, Cappellini MD, Kraus D, et al
    Haematological effects of oral administration of bitopertin, a glycine transport inhibitor, in patients with non-transfusion-dependent beta-thalassaemia.
    Br J Haematol. 2021;194:474-477.
    >> Share

  264. WICKRAMASINGHE W, Dissanayake R, Raj R, Gooneratne L, et al
    The first report of allogeneic haematopoietic stem cell transplantations for bone marrow failure performed in Sri Lanka.
    Br J Haematol. 2021;194:e56-e58.
    >> Share

  265. TAMAGNE M, Pakdaman S, Bartolucci P, Habibi A, et al
    Whole-blood CCR7 expression and chemoattraction in red blood cell alloimmunization.
    Br J Haematol. 2021;194:477-481.
    >> Share

  266. RIEU JB, El Kassir A, Largeaud L, Dion J, et al
    Characteristic vacuolisation of granulocytic and erythroid precursors associated with VEXAS syndrome.
    Br J Haematol. 2021;194:8.
    >> Share

  267. WARE RE, Dertinger SD
    Absence of hydroxyurea-induced mutational effects supports higher utilisation for the treatment of sickle cell anaemia.
    Br J Haematol. 2021;194:252-266.
    >> Share

  268. PACE BS, Starlard-Davenport A, Kutlar A
    Sickle cell disease: progress towards combination drug therapy.
    Br J Haematol. 2021;194:240-251.
    >> Share

    June 2021
  269. PATON C, Mathews L, Groarke EM, Rios O, et al
    COVID-19 infection in patients with severe aplastic anaemia.
    Br J Haematol. 2021;193:902-905.
    >> Share

  270. HANDS K, Taylor C, Kotze A, Richards T, et al
    Preoperative patient blood management during the SARS-CoV-2 pandemic.
    Br J Haematol. 2021;193:1087-1092.
    >> Share

  271. STEINBERG MH
    HbA2 induction: the merit of pancellularity in sickle cell disease.
    Br J Haematol. 2021;193:1032-1033.
    >> Share

  272. HILLS RK
    Diagnosing Diamond-Blackfan anaemia: 'Vorsprung durch Technik'.
    Br J Haematol. 2021;193:1030-1031.
    >> Share

  273. BLAISE D, Savani BN
    Alternative donor transplantation for severe aplastic anaemia in 2021: haplo donor, cord blood or both?
    Br J Haematol. 2021;193:863-864.
    >> Share

  274. PORCU S, Simbula M, Marongiu MF, Perra A, et al
    Delta-globin gene expression improves sickle cell disease in a humanised mouse model.
    Br J Haematol. 2021;193:1228-1237.
    >> Share

  275. VAN DOOIJEWEERT B, Broeks MH, van Beers EJ, Verhoeven-Duif NM, et al
    Dried blood spot metabolomics reveals a metabolic fingerprint with diagnostic potential for Diamond Blackfan Anaemia.
    Br J Haematol. 2021;193:1185-1193.
    >> Share

  276. LIANG Y, Zhang X, Liu Y, Wang L, et al
    GATA zinc finger domain-containing protein 2A (GATAD2A) deficiency reactivates fetal haemoglobin in patients with beta-thalassaemia through impaired formation of methyl-binding domain protein 2 (MBD2)-containing nucleosome remodelling and deacetylatio
    Br J Haematol. 2021;193:1220-1227.
    >> Share

  277. CHILDS RW, Tian X, Vo P, Purev E, et al
    Combined haploidentical and cord blood transplantation for refractory severe aplastic anaemia and hypoplastic myelodysplastic syndrome.
    Br J Haematol. 2021;193:951-960.
    >> Share

  278. MAITLAND K, Kiguli S, Olupot-Olupot P, Opoka RO, et al
    Transfusion management of severe anaemia in African children: a consensus algorithm.
    Br J Haematol. 2021;193:1247-1259.
    >> Share

  279. LAAS C, Lambert C, Senior McKenzie T, Sheldon E, et al
    Improving the laboratory diagnosis of pyruvate kinase deficiency.
    Br J Haematol. 2021;193:994-1000.
    >> Share

  280. JANG T, Mo G, Stewart C, Egini O, et al
    Antibiotic use in adults during sickle cell vaso-occlusive crisis: Is it time for a controlled trial?
    Br J Haematol. 2021;193:1281-1283.
    >> Share

  281. MARTINO S, Arlet JB, Odievre MH, Jullien V, et al
    Deficient mitophagy pathways in sickle cell disease.
    Br J Haematol. 2021;193:988-993.
    >> Share

  282. XU Y, Alfaro-Magallanes VM, Babitt JL
    Physiological and pathophysiological mechanisms of hepcidin regulation: clinical implications for iron disorders.
    Br J Haematol. 2021;193:882-893.
    >> Share

  283. JUNG M, Mehta PA, Jiang CS, Rosti RO, et al
    Comparison of the clinical phenotype and haematological course of siblings with Fanconi anaemia.
    Br J Haematol. 2021;193:971-975.
    >> Share

    May 2021
  284. UYOGA S, George EC, Bates I, Olupot-Olupot P, et al
    Point-of-care haemoglobin testing in African hospitals: a neglected essential diagnostic test.
    Br J Haematol. 2021 May 15. doi: 10.1111/bjh.17431.
    >> Share

  285. BARCELLINI W, Colombatti R
    The impact of Parvovirus B19 on hereditary haemolytic anaemias.
    Br J Haematol. 2021;193:703-704.
    >> Share

  286. BOOTH GS, Savani BN, Langston AA
    Pure red blood cell aplasia: patient management pitfalls in major ABO-incompatible haematopoietic cell transplantation.
    Br J Haematol. 2021;193:701-702.
    >> Share

  287. ELBADRY MI, Khaled SAA, Ahmed NM, Abudeif A, et al
    Acute human parvovirus B19 infection triggers immune-mediated transient bone marrow failure syndrome, extreme direct hyperbilirubinaemia and acute hepatitis in patients with hereditary haemolytic anaemias: multicentre prospective pathophysiological st
    Br J Haematol. 2021;193:827-840.
    >> Share

  288. LONGVAL T, Galimard JE, Lepretre AC, Suarez F, et al
    Treatment for pure red cell aplasia after major ABO-incompatible allogeneic stem cell transplantation: a multicentre study.
    Br J Haematol. 2021;193:814-826.
    >> Share

  289. VINCHI F, Sparla R, Passos ST, Sharma R, et al
    Vasculo-toxic and pro-inflammatory action of unbound haemoglobin, haem and iron in transfusion-dependent patients with haemolytic anaemias.
    Br J Haematol. 2021;193:637-658.
    >> Share

  290. RUND D
    Intravenous iron: do we adequately understand the short- and long-term risks in clinical practice?
    Br J Haematol. 2021;193:466-480.
    >> Share

  291. SARAF SL, Zhang X, Shah BN, Raslan R, et al
    Engulfment and cell motility 1 (ELMO1) and apolipoprotein A1 (APOA1) as candidate genes for sickle cell nephropathy.
    Br J Haematol. 2021;193:628-632.
    >> Share

  292. DENTON CC, Detterich JA, Coates TD, Wood JC, et al
    Kidney iron deposition by R2* is associated with haemolysis and urinary iron.
    Br J Haematol. 2021;193:633-636.
    >> Share

    April 2021
  293. BERNARD F, Uppungunduri CRS, Meyer S, Cummins M, et al
    Excellent overall and chronic graft-versus-host-disease-free event-free survival in Fanconi anaemia patients undergoing matched related- and unrelated-donor bone marrow transplantation using alemtuzumab-Flu-Cy: the UK experience.
    Br J Haematol. 2021 Apr 14. doi: 10.1111/bjh.17418.
    >> Share

  294. CALABRETTA E, Moraleda JM, Iacobelli M, Jara R, et al
    COVID-19-induced endotheliitis: emerging evidence and possible therapeutic strategies.
    Br J Haematol. 2021;193:43-51.
    >> Share

  295. BENNETT R, Ruskova A
    Atezolizumab-induced pure red cell aplasia.
    Br J Haematol. 2021;193:10.
    >> Share

  296. LADU AI, Aiyenigba AO, Adekile A, Bates I, et al
    The spectrum of splenic complications in patients with sickle cell disease in Africa: a systematic review.
    Br J Haematol. 2021;193:26-42.
    >> Share

  297. SHAFIEE S, Gelebart P, Popa M, Hellesoy M, et al
    Preclinical characterisation and development of a novel myelodysplastic syndrome-derived cell line.
    Br J Haematol. 2021;193:415-419.
    >> Share

  298. CHENG Y, Shang X, Chen D, Pang D, et al
    MicroRNA-2355-5p regulates gamma-globin expression in human erythroid cells by inhibiting KLF6.
    Br J Haematol. 2021;193:401-405.
    >> Share

  299. QUINTINO DE OLIVEIRA B, Catto LFB, Santana BAA, Tellechea MF, et al
    Eltrombopag preferentially expands haematopoietic multipotent progenitors in human aplastic anaemia.
    Br J Haematol. 2021;193:410-414.
    >> Share

    March 2021
  300. SAULSBERRY-ABATE AC, Partanen M, Porter JS, Podila PSB, et al
    Cognitive performance as a predictor of healthcare transition in sickle cell disease.
    Br J Haematol. 2021;192:1082-1091.
    >> Share

  301. AL-SAMKARI H, Addonizio K, Glader B, Morton DH, et al
    The pyruvate kinase (PK) to hexokinase enzyme activity ratio and erythrocyte PK protein level in the diagnosis and phenotype of PK deficiency.
    Br J Haematol. 2021;192:1092-1096.
    >> Share

  302. EGOT M, Lasne D, Poirault-Chassac S, Mirault T, et al
    Role of oculocerebrorenal syndrome of Lowe (OCRL) protein in megakaryocyte maturation, platelet production and functions: a study in patients with Lowe syndrome.
    Br J Haematol. 2021;192:909-921.
    >> Share

  303. ATAGA KI, Staffa SJ, Brugnara C, Stocker JW, et al
    Haemoglobin response to senicapoc in patients with sickle cell disease: a re-analysis of the Phase III trial.
    Br J Haematol. 2021;192:e129-e132.
    >> Share

  304. OIKONOMOPOULOU C, Paisiou A, Komitopoulou A, Ioannidou ED, et al
    Increased incidence of autoimmune cytopenias after allogeneic haematopoietic stem cell transplantation using a matched unrelated donor in children with beta-thalassaemia.
    Br J Haematol. 2021;192:e127-e129.
    >> Share

  305. SACHDEV V, Tian X, Gu Y, Nichols J, et al
    A phenotypic risk score for predicting mortality in sickle cell disease.
    Br J Haematol. 2021;192:932-941.
    >> Share

  306. RIBEIRO PR, Teixeira RDS, Souza AR, Pereira TCS, et al
    Blood plasma metabolomics of children and adolescents with sickle cell anaemia treated with hydroxycarbamide: a new tool for uncovering biochemical alterations.
    Br J Haematol. 2021;192:922-931.
    >> Share

    February 2021
  307. CAIRO MS, Savani BN
    Haematopoietic progenitor cell transplantation in adults with symptomatic sickle cell disease: the time has arrived.
    Br J Haematol. 2021;192:678-680.
    >> Share

  308. OLSON TS
    Paediatric severe aplastic anaemia treatment: where to start?
    Br J Haematol. 2021;192:417-419.
    >> Share

  309. ALZAHRANI M, Damlaj M, Jeffries N, Alahmari B, et al
    Non-myeloablative human leukocyte antigen-matched related donor transplantation in sickle cell disease: outcomes from three independent centres.
    Br J Haematol. 2021;192:761-768.
    >> Share

  310. YUAN S, Jordan LC, Davis LT, Cogswell PM, et al
    A cross-sectional, case-control study of intracranial arterial wall thickness and complete blood count measures in sickle cell disease.
    Br J Haematol. 2021;192:769-777.
    >> Share

  311. GROARKE EM, Patel BA, Gutierrez-Rodrigues F, Rios O, et al
    Eltrombopag added to immunosuppression for children with treatment-naive severe aplastic anaemia.
    Br J Haematol. 2021;192:605-614.
    >> Share

  312. HOTINSKI AK, Best OG, Thurgood LA, Lower KM, et al
    A biclonal case of chronic lymphocytic leukaemia with discordant mutational status of the immunoglobulin heavy chain variable region and bimodal CD49d expression.
    Br J Haematol. 2021;192:e77-e81.
    >> Share

  313. DEMBELE AK, Lapoumeroulie C, Diaw M, Tessougue O, et al
    Cell-derived microparticles and sickle cell disease chronic vasculopathy in sub-Saharan Africa: A multinational study.
    Br J Haematol. 2021;192:634-642.
    >> Share

  314. VITRANO A, Meloni A, Addario Pollina W, Karimi M, et al
    A complication risk score to evaluate clinical severity of thalassaemia syndromes.
    Br J Haematol. 2021;192:626-633.
    >> Share

  315. CASTLEMAN JS, Moise KJ Jr, Kilby MD
    Medical therapy to attenuate fetal anaemia in severe maternal red cell alloimmunisation.
    Br J Haematol. 2021;192:425-432.
    >> Share

    January 2021
  316. KULASEKARARAJ AG, Marsh JCW
    Romiplostim in aplastic anaemia - another tool in the armamentarium.
    Br J Haematol. 2021;192:15-16.
    >> Share

  317. MINGOIA M, Caria CA, Ye L, Asunis I, et al
    Induction of therapeutic levels of HbF in genome-edited primary beta(0) 39-thalassaemia haematopoietic stem and progenitor cells.
    Br J Haematol. 2021;192:395-404.
    >> Share


  318. Developing the evidence base for the management of autoimmune haemolytic anaemia (AIHA): the UK experience.
    Br J Haematol. 2021;192:e54-e57.
    >> Share

  319. SHARMA POUDYAL B, Gyawali B, Rondelli D
    The need for locally generated data in haematology: a real-world experience of aplastic anaemia in Nepal.
    Br J Haematol. 2021;192:e63-e65.
    >> Share

  320. GREGOIRE-PELCHAT P, Pastore Y, Robitaille N, LeMay S, et al
    Comparison of two vitamin D supplementation strategies in children with sickle cell disease: a randomized controlled trial.
    Br J Haematol. 2021;192:385-394.
    >> Share

  321. PATEL A, Gan K, Li AA, Weiss J, et al
    Machine-learning algorithms for predicting hospital re-admissions in sickle cell disease.
    Br J Haematol. 2021;192:158-170.
    >> Share

  322. JANG JH, Tomiyama Y, Miyazaki K, Nagafuji K, et al
    Efficacy and safety of romiplostim in refractory aplastic anaemia: a Phase II/III, multicentre, open-label study.
    Br J Haematol. 2021;192:190-199.
    >> Share

  323. CHAN LKL, Mak VWM, Chan SCH, Yu ELM, et al
    Liver complications of haemoglobin H disease in adults.
    Br J Haematol. 2021;192:171-178.
    >> Share

  324. MTENGA J, Orf K, Zheng J, Chamba C, et al
    Haematopoietic stem cell transplantation in Tanzania.
    Br J Haematol. 2021;192:17-21.
    >> Share

  325. SPEICH C, Wegmuller R, Brittenham GM, Zeder C, et al
    Measurement of long-term iron absorption and loss during iron supplementation using a stable isotope of iron ((57) Fe).
    Br J Haematol. 2021;192:179-189.
    >> Share

  326. MANARA R, Dalla Torre A, Lucchetta M, Ermani M, et al
    Visual cortex changes in children with sickle cell disease and normal visual acuity: a multimodal magnetic resonance imaging study.
    Br J Haematol. 2021;192:151-157.
    >> Share

    December 2020
  327. RUND D
    The evolution of clinical research in thalassaemia: where has all the funding gone?
    Br J Haematol. 2020;191:666-667.
    >> Share

  328. JOBANPUTRA M, Paramore C, Laird SG, McGahan M, et al
    Co-morbidities and mortality associated with transfusion-dependent beta-thalassaemia in patients in England: a 10-year retrospective cohort analysis.
    Br J Haematol. 2020;191:897-905.
    >> Share

  329. URIO F, Nkya S, Rooks H, Mgaya JA, et al
    F cell numbers are associated with an X-linked genetic polymorphism and correlate with haematological parameters in patients with sickle cell disease.
    Br J Haematol. 2020;191:888-896.
    >> Share

  330. FORTE S, Eng B, Verhovsek M, Soulieres D, et al
    Microcytosis in patients with haemoglobin C trait: is alpha-thalassaemia trait to blame?
    Br J Haematol. 2020;191:e129-e131.
    >> Share

  331. TANG D, Liu S, Sun H, Qin X, et al
    All-trans-retinoic acid shifts Th1 towards Th2 cell differentiation by targeting NFAT1 signalling to ameliorate immune-mediated aplastic anaemia.
    Br J Haematol. 2020;191:906-919.
    >> Share

  332. PECKER LH, Hussain S, Christianson MS, Lanzkron S, et al
    Hydroxycarbamide exposure and ovarian reserve in women with sickle cell disease in the Multicenter Study of Hydroxycarbamide.
    Br J Haematol. 2020;191:880-887.
    >> Share

  333. VALI S, Mukhtar S, Nandi A, Wilson K, et al
    Cumulative outcome of pre-implantation genetic diagnosis for sickle cell disease: a 5-year review.
    Br J Haematol. 2020;191:875-879.
    >> Share

    November 2020
  334. VERLHAC S, Gabor F, Paillard C, Chateil JF, et al
    Improved stenosis outcome in stroke-free sickle cell anemia children after transplantation compared to chronic transfusion.
    Br J Haematol. 2020 Nov 20. doi: 10.1111/bjh.17178.
    >> Share

  335. WEI Z, Yang G, Huang Y, Peng P, et al
    A 15-years follow-up of deferasirox in beta-thalassaemia major patients with iron overload.
    Br J Haematol. 2020;191:e81-e83.
    >> Share

  336. PEZINA-CANTU C, Gomez-De Leon A, Jaime-Perez JC, Colunga-Pedraza P, et al
    Pernicious anaemia can be treated effectively with a single high dose of cobalamin.
    Br J Haematol. 2020;191:e97-e100.
    >> Share

  337. SIRIWORADETKUN S, Thubthed R, Thiengtavor C, Paiboonsukwong K, et al
    Elevated levels of circulating monocytic myeloid derived suppressor cells in splenectomised beta-thalassaemia/HbE patients.
    Br J Haematol. 2020;191:e72-e76.
    >> Share

  338. HAN J, Holden CC, Ahluwalia AY, Molokie RE, et al
    Chronic opioid use can be reduced or discontinued after haematopoietic stem cell transplantation for sickle cell disease.
    Br J Haematol. 2020;191:e70-e72.
    >> Share

  339. PEFFAULT DE LATOUR R, Brodsky RA, Ortiz S, Risitano AM, et al
    Pharmacokinetic and pharmacodynamic effects of ravulizumab and eculizumab on complement component 5 in adults with paroxysmal nocturnal haemoglobinuria: results of two phase 3 randomised, multicentre studies.
    Br J Haematol. 2020;191:476-485.
    >> Share

  340. TOLE S, Dhir P, Pugi J, Drury LJ, et al
    Genotype-phenotype correlation in children with hereditary spherocytosis.
    Br J Haematol. 2020;191:486-496.
    >> Share

    October 2020
  341. HERISHANU Y, Levi S, Kamdjou T, Bornstein Y, et al
    Obinutuzumab in the treatment of autoimmune haemolytic anaemia and immune thrombocytopenia in patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma.
    Br J Haematol. 2020 Oct 23. doi: 10.1111/bjh.17105.
    >> Share

  342. SHEHA D, El-Shayeb M, Eid Y, Amin M, et al
    Unfolding of sickle cell trait by coronavirus disease 2019 (COVID-19) infection.
    Br J Haematol. 2020;191:e38-e40.
    >> Share

  343. PIKE A, Muus P, Munir T, Mitchell L, et al
    COVID-19 infection in patients on anti-complement therapy: The Leeds National Paroxysmal Nocturnal Haemoglobinuria service experience.
    Br J Haematol. 2020;191:e1-e4.
    >> Share

  344. ROIZENBLATT S, Cabanas-Pedro AC, Figueiredo MS
    Rheumatoid arthritis and sickle cell disease: A potential association.
    Br J Haematol. 2020;191:e25-e28.
    >> Share

  345. BARGEHR C, Crazzolara R
    Cabot rings and other peripheral blood features of Imerslund-Grasbeck syndrome.
    Br J Haematol. 2020;191:11.
    >> Share

  346. TEOFILI L, Papacci P, Orlando N, Bianchi M, et al
    Allogeneic cord blood transfusions prevent fetal haemoglobin depletion in preterm neonates. Results of the CB-TrIP study.
    Br J Haematol. 2020;191:263-268.
    >> Share

  347. RICCHI P, Meloni A, Pistoia L, Spasiano A, et al
    Longitudinal follow-up of patients with thalassaemia intermedia who started transfusion therapy in adulthood: a cohort study.
    Br J Haematol. 2020;191:107-114.
    >> Share

    September 2020
  348. NESR G, Koshy R, Foldes D, Kagdi H, et al
    Autoimmune haemolytic anaemia and a marked rise in the lymphocyte count associated with COVID-19 in a patient with treatment-naive chronic lymphocytic leukaemia: a case report.
    Br J Haematol. 2020;190:e326-e328.
    >> Share

  349. OLATUNYA OS
    Poverty and severity of childhood sickle cell disease.
    Br J Haematol. 2020;190:819-821.
    >> Share

  350. WOUTERS HJCM, Stam SP, van der Klauw MM, Bakker SJL, et al
    The association between haemoglobin concentrations and muscle mass determined from urinary creatinine excretion rate: a population-based cohort study.
    Br J Haematol. 2020;190:e349-e352.
    >> Share

  351. GERARD D, Bourin S, Phulpin A, Picard V, et al
    Previously misdiagnosed red cell membrane disorder and familial consequences.
    Br J Haematol. 2020;190:810.
    >> Share

  352. LIAPIS K, Vrachiolias G, Spanoudakis E, Kotsianidis I, et al
    Vacuolation of early erythroblasts with ring sideroblasts: a clue to the diagnosis of linezolid toxicity.
    Br J Haematol. 2020;190:809.
    >> Share

  353. MCGINNIS E, Smith TW
    Clostridium perfringens sepsis with spherocytosis and green neutrophil inclusions.
    Br J Haematol. 2020;190:641.
    >> Share

  354. DE SANTIS GC, Costa TCM, Santos FLS, da Silva-Pinto AC, et al
    Blood transfusion support for sickle cell patients during haematopoietic stem cell transplantation: a single-institution experience.
    Br J Haematol. 2020;190:e295-e297.
    >> Share

  355. BELLO-MANGA H, Galadanci AA, Abdullahi S, Ali S, et al
    Low educational level of head of household, as a proxy for poverty, is associated with severe anaemia among children with sickle cell disease living in a low-resource setting: evidence from the SPRING trial.
    Br J Haematol. 2020;190:939-944.
    >> Share

    August 2020
  356. APPIAH-KUBI A, Acharya S, Fein Levy C, Vlachos A, et al
    Varying presentations and favourable outcomes of COVID-19 infection in children and young adults with sickle cell disease: an additional case series with comparisons to published cases.
    Br J Haematol. 2020;190:e221-e224.
    >> Share

  357. KULASEKARARAJ AG
    Regulatory cells in immune-mediated aplastic anaemia - not Tregs but Bregs.
    Br J Haematol. 2020;190:486-487.
    >> Share

  358. GIBSON JS
    A novel mechanism for pathogenesis of sickle cell disease with therapeutic implications: Band 3 tyrosine phosphorylation.
    Br J Haematol. 2020;190:488-489.
    >> Share

  359. COLOMBATTI R, Andemariam B
    Microvasculopathy and biomarkers in sickle cell disease: the promise of non-invasive real-time in vivo tools.
    Br J Haematol. 2020;190:309-310.
    >> Share

  360. MALINOWSKI AK
    Thrombotic microangiopathy in pregnancy: when you hear hoofbeats, consider the zebras?
    Br J Haematol. 2020;190:306-308.
    >> Share

  361. MOURA PL, Dobbe JGG, Streekstra GJ, Rab MAE, et al
    Rapid diagnosis of hereditary haemolytic anaemias using automated rheoscopy and supervised machine learning.
    Br J Haematol. 2020;190:e250-e255.
    >> Share

  362. ANDREWS C, Maze D, Murphy T, Sibai H, et al
    Combination treatment with CPX-351 and midostaurin in patients with secondary acute myeloid leukaemia that are FLT3 mutated: three cases and review of literature.
    Br J Haematol. 2020;190:467-470.
    >> Share

  363. FILIPPIDOU M, Avgerinou G, Tsipou H, Tourkantoni N, et al
    Longitudinal evaluation of eltrombopag in paediatric acquired severe aplastic anaemia.
    Br J Haematol. 2020;190:e157-e159.
    >> Share

  364. FUNG EB, Ahmad T, Killilea DW, Hussain R, et al
    Zinc supplementation improves markers of glucose homeostasis in thalassaemia.
    Br J Haematol. 2020;190:e162-e166.
    >> Share

  365. LUEWAN S, Charoenkwan P, Sirichotiyakul S, Tongsong T, et al
    Fetal haemoglobin H-Constant Spring disease: a role for intrauterine management.
    Br J Haematol. 2020;190:e233-e236.
    >> Share

  366. NOOMUNA P, Risinger M, Zhou S, Seu K, et al
    Inhibition of Band 3 tyrosine phosphorylation: a new mechanism for treatment of sickle cell disease.
    Br J Haematol. 2020;190:599-609.
    >> Share

  367. TIMMERMANS SAMEG, Werion A, Spaanderman MEA, Reutelingsperger CP, et al
    The natural course of pregnancies in women with primary atypical haemolytic uraemic syndrome and asymptomatic relatives.
    Br J Haematol. 2020;190:442-449.
    >> Share

  368. ZAIMOKU Y, Patel BA, Kajigaya S, Feng X, et al
    Deficit of circulating CD19(+) CD24(hi) CD38(hi) regulatory B cells in severe aplastic anaemia.
    Br J Haematol. 2020;190:610-617.
    >> Share

  369. SAMARRON SL, Miller JW, Cheung AT, Chen PC, et al
    Homocysteine is associated with severity of microvasculopathy in sickle cell disease patients.
    Br J Haematol. 2020;190:450-457.
    >> Share

  370. WILSON S, Ellsworth P, Key NS
    Pregnancy in sickle cell trait: what we do and don't know.
    Br J Haematol. 2020;190:328-335.
    >> Share

    July 2020
  371. CHAKRAVORTY S, Rees D
    Commentary on sickle cell non-invasive prenatal testing article.
    Br J Haematol. 2020;190:20-21.
    >> Share

  372. JEREBTSOVA M, Taye A, Smith N, Afangbedji N, et al
    Association between plasma and urinary orosomucoid and chronic kidney disease in adults with sickle cell disease.
    Br J Haematol. 2020;190:e45-e48.
    >> Share

  373. PEDROSA AM, Lemes RPG
    Gene expression of HIF-1alpha and VEGF in response to hypoxia in sickle cell anaemia: Influence of hydroxycarbamide.
    Br J Haematol. 2020;190:e39-e42.
    >> Share

  374. NARDO-MARINO A, Brousse V, Rees D
    Emerging therapies in sickle cell disease.
    Br J Haematol. 2020;190:149-172.
    >> Share

  375. KATTAMIS A
    Diamond-Blackfan anaemia: understanding an old disease.
    Br J Haematol. 2020;190:14-15.
    >> Share

  376. VAN CAMPEN J, Silcock L, Yau S, Daniel Y, et al
    A novel non-invasive prenatal sickle cell disease test for all at-risk pregnancies.
    Br J Haematol. 2020;190:119-124.
    >> Share

  377. QUARELLO P, Garelli E, Carando A, Cillario R, et al
    A 20-year long term experience of the Italian Diamond-Blackfan Anaemia Registry: RPS and RPL genes, different faces of the same disease?
    Br J Haematol. 2020;190:93-104.
    >> Share

    June 2020
  378. LUZZATTO L
    PNH phenotypes and their genesis.
    Br J Haematol. 2020;189:802-805.
    >> Share

  379. HYACINTH HI, Idris IM
    Cognitive deficit in sickle cell disease: Is hydroxyurea part of the story?
    Br J Haematol. 2020;189:1014-1015.
    >> Share

  380. GIRELLI D, Busti F
    ERFE regulation in sickle cell disease: complex but promising.
    Br J Haematol. 2020;189:1012-1013.
    >> Share

  381. KHAMPHIKHAM P, Nualkaew T, Pongpaksupasin P, Kaewsakulthong W, et al
    High-level induction of fetal haemoglobin by pomalidomide in beta-thalassaemia/HbE erythroid progenitor cells.
    Br J Haematol. 2020;189:e240-e245.
    >> Share

  382. BREWIN JN, Crowley MP, Kesse-Adu R, Stuart-Smith S, et al
    Catheter associated thromboses in patients with sickle cell anaemia and dual lumen Vortex apheresis ports are common and can be clinically asymptomatic.
    Br J Haematol. 2020;189:e198-e200.
    >> Share

  383. PARTANEN M, Kang G, Wang WC, Krull K, et al
    Association between hydroxycarbamide exposure and neurocognitive function in adolescents with sickle cell disease.
    Br J Haematol. 2020;189:1192-1203.
    >> Share

  384. RICHARDS SJ, Dickinson AJ, Cullen MJ, Griffin M, et al
    Presentation clinical, haematological and immunophenotypic features of 1081 patients with GPI-deficient (paroxysmal nocturnal haemoglobinuria) cells detected by flow cytometry.
    Br J Haematol. 2020;189:954-966.
    >> Share

  385. PRATS-MARTIN C, Mezquita L, Garcia-Canale S, Jimenez-Jambrina M, et al
    Numerous abnormal mitoses in parvovirus B19-infected proerythroblasts.
    Br J Haematol. 2020;189:800.
    >> Share

  386. MANGAONKAR AA, Thawer F, Son J, Ajebo G, et al
    Regulation of iron homeostasis through the erythroferrone-hepcidin axis in sickle cell disease.
    Br J Haematol. 2020;189:1204-1209.
    >> Share

  387. AL-ALI HK, Griesshammer M, Foltz L, Palumbo GA, et al
    Primary analysis of JUMP, a phase 3b, expanded-access study evaluating the safety and efficacy of ruxolitinib in patients with myelofibrosis, including those with low platelet counts.
    Br J Haematol. 2020;189:888-903.
    >> Share

  388. PATEL BJ, Barot SV, Kuzmanovic T, Kerr C, et al
    Distinctive and common features of moderate aplastic anaemia.
    Br J Haematol. 2020;189:967-975.
    >> Share

    May 2020
  389. ANTELO G, Mangaonkar AA, Coltro G, Buradkar A, et al
    Response to erythropoiesis-stimulating agents in patients with WHO-defined myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T).
    Br J Haematol. 2020;189:e104-e108.
    >> Share

  390. SHAH BN, Hassan TO, Zhang X, McClain DA, et al
    Increased iron stores influence glucose metabolism in sickle cell anaemia.
    Br J Haematol. 2020;189:e184-e187.
    >> Share

  391. SKINNER S, Ling Liu K, Lo M, Josset-Lamaugarny A, et al
    Alterations in vascular reactivity in a transgenic mouse model of sickle cell trait.
    Br J Haematol. 2020;189:e154-e157.
    >> Share

  392. GOUVEIA C, Duarte M, Norte S, Alves P, et al
    Osteoarticular infections in paediatric sickle cell disease: in the era of multidrugresistant bacteria.
    Br J Haematol. 2020;189:e147-e150.
    >> Share

  393. PHILIP KEJ, Sadaka AS, Polkey MI, Hopkinson NS, et al
    The prevalence and associated mortality of non-anaemic iron deficiency in older adults: a 14 years observational cohort study.
    Br J Haematol. 2020;189:566-572.
    >> Share

  394. LEONARD A, Tisdale J, Abraham A
    Curative options for sickle cell disease: haploidentical stem cell transplantation or gene therapy?
    Br J Haematol. 2020;189:408-423.
    >> Share

  395. MCCORMICK M, Richardson T, Warady BA, Novelli EM, et al
    Acute kidney injury in paediatric patients with sickle cell disease is associated with increased morbidity and resource utilization.
    Br J Haematol. 2020;189:559-565.
    >> Share

    April 2020
  396. ALI JS, Andrasik F, Berlin KS, Porter J, et al
    Attention difficulties are associated with lower engagement in adult care amongst youth with sickle cell disease.
    Br J Haematol. 2020;189:e27-e30.
    >> Share

  397. FAYAND A, Dzierzynski N, Georgin-Lavialle S, Bachmeyer C, et al
    The association of psychiatric comorbidities with emergency visits and hospitalisations in adult sickle-cell patients: a cohort study.
    Br J Haematol. 2020;189:e21-e23.
    >> Share

  398. ROPER D, Layton M, Rees D, Lambert C, et al
    Laboratory diagnosis of G6PD deficiency. A British Society for Haematology Guideline.
    Br J Haematol. 2020;189:24-38.
    >> Share

  399. THIENGTAVOR C, Siriworadetkun S, Paiboonsukwong K, Fucharoen S, et al
    Increased ferritin levels in non-transfusion-dependent beta degrees -thalassaemia/HbE are associated with reduced CXCR2 expression and neutrophil migration.
    Br J Haematol. 2020;189:187-198.
    >> Share

  400. FUJISAWA M, Yasumoto A, Kato H, Sugawara Y, et al
    The role of anti-complement factor H antibodies in the development of atypical haemolytic uremic syndrome: a possible contribution to abnormality of platelet function.
    Br J Haematol. 2020;189:182-186.
    >> Share

  401. NICKEL RS, Horan JT, Abraham A, Qayed M, et al
    Human leukocyte antigen (HLA) class I antibodies and transfusion support in paediatric HLA-matched haematopoietic cell transplant for sickle cell disease.
    Br J Haematol. 2020;189:162-170.
    >> Share

  402. QUARTA A, Sgherza N, Pasanisi A, Solfrizzi MP, et al
    Switching from dispersible to film coated tablet formulation of deferasirox improves hemoglobin levels and transfusional interval in patients with transfusion-dependent-thalassemia.
    Br J Haematol. 2020;189:e60-e63.
    >> Share

    March 2020
  403. AUERBACH M, Georgieff MK
    Guidelines for iron deficiency in pregnancy: hope abounds: Commentary to accompany: UK guidelines on the management of iron deficiency in pregnancy.
    Br J Haematol. 2020;188:814-816.
    >> Share

  404. AGGARWAL A, Jamwal M, Sharma P, Sachdeva MUS, et al
    Deciphering molecular heterogeneity of Indian families with hereditary spherocytosis using targeted next-generation sequencing: First South Asian study.
    Br J Haematol. 2020;188:784-795.
    >> Share

  405. HANSEN S, Wood DK, Higgins JM
    5-(Hydroxymethyl)furfural restores low-oxygen rheology of sickle trait blood in vitro.
    Br J Haematol. 2020;188:985-993.
    >> Share

  406. CORNELISSE AC, Bergkamp FJM, Griffioen-Keijzer A
    Haemolytic anaemia: an unrecognised side effect of hydroxyurea?
    Br J Haematol. 2020;188:e80-e81.
    >> Share

  407. STALLINGS AM, Majhail NS, Nowacki AS, Onimoe GI, et al
    Paediatric haematologists' attitudes regarding haematopoietic cell transplantation as treatment for sickle cell disease.
    Br J Haematol. 2020;188:976-984.
    >> Share

  408. PAVORD S, Daru J, Prasannan N, Robinson S, et al
    UK guidelines on the management of iron deficiency in pregnancy.
    Br J Haematol. 2020;188:819-830.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016